These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28993777)

  • 1. The Procoagulant Activity of Apoptotic Cells Is Mediated by Interaction with Factor XII.
    Yang A; Chen F; He C; Zhou J; Lu Y; Dai J; Birge RB; Wu Y
    Front Immunol; 2017; 8():1188. PubMed ID: 28993777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway.
    Vu TT; Leslie BA; Stafford AR; Zhou J; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2016 Jan; 115(1):89-98. PubMed ID: 26354857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.
    Noubouossie DF; Henderson MW; Mooberry M; Ilich A; Ellsworth P; Piegore M; Skinner SC; Pawlinski R; Welsby I; Renné T; Hoffman M; Monroe DM; Key NS
    Blood; 2020 Mar; 135(10):755-765. PubMed ID: 31971571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII activation is essential to sustain the procoagulant effects of particulate matter.
    Kilinç E; Van Oerle R; Borissoff JI; Oschatz C; Gerlofs-Nijland ME; Janssen NA; Cassee FR; Sandström T; Renné T; Ten Cate H; Spronk HM
    J Thromb Haemost; 2011 Jul; 9(7):1359-67. PubMed ID: 21481175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation.
    Gershom ES; Sutherland MR; Lollar P; Pryzdial EL
    J Thromb Haemost; 2010 May; 8(5):1037-43. PubMed ID: 20128864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.
    Ghebrehiwet B; CebadaMora C; Tantral L; Jesty J; Peerschke EI
    Adv Exp Med Biol; 2006; 586():95-105. PubMed ID: 16893067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood.
    Wan J; Dhrolia S; Kasthuri RR; Prokopenko Y; Ilich A; Saha P; Roest M; Wolberg AS; Key NS; Pawlinski R; Bendapudi PK; Mackman N; Grover SP
    Blood Adv; 2024 Jun; 8(12):3045-3057. PubMed ID: 38593231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma contact activation by a fucosylated chondroitin sulfate and its structure-activity relationship study.
    Lin L; Xu L; Xiao C; Zhou L; Gao N; Wu M; Zhao J
    Glycobiology; 2018 Oct; 28(10):754-764. PubMed ID: 30016441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.